Abiopharma

Kiora Pharmaceuticals Reports Second Quarter 2025 Results; Company Advances Pipeline with Two Active Phase 2 Clinical Trials for Retinal Diseases

CONMED Corporation Announces Quarterly Cash Dividend

New Form 8-K - SURMODICS INC Filed: 2025-08-08 AccNo: 0000950170-25-105461 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

New Form 8-K - ANI PHARMACEUTICALS INC Filed: 2025-08-08 AccNo: 0001023024-25-000081 Size: 540 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance

New Form 10-Q - Canopy Growth Corp Filed: 2025-08-08 AccNo: 0001193125-25-175982 Size: 16 MB

New Form 6-K - DR REDDYS LABORATORIES LTD Filed: 2025-08-08 AccNo: 0001575872-25-000520 Size: 4 MB

New Form 6-K - GSK plc Filed: 2025-08-08 AccNo: 0001654954-25-009240 Size: 32 KB

Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments

New Form 6-K - GSK plc Filed: 2025-08-08 AccNo: 0001654954-25-009238 Size: 7 MB

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

Riverstone Holdings Limited - Announcement

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT, 2016